Results
75,408 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 7 | Grawunder UlfDirector |  ADAGAdagene Inc.Grant or award · 10b5-1 plan | A | — 20.0K sh | Aug 14, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 7 | Grawunder UlfDirector | ADAGAdagene Inc. Grant or award · 10b5-1 plan | A | — 20.0K sh | Aug 14, 2026 |
| 5 | Carroll Patrick HarrisonChief Medical Officer |  HIMSHims & Hers Health, Inc.Grant or award | A | — 260 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Fukushima RyanCEO, Data |  TEMTempus AI, Inc.Gift | G | — 62.2K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Russell Alan JDirector, Chief Scientific Officer |  EWTXEdgewise Therapeutics, Inc.Grant or award | A | — 65.0K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Autor Deborah M.Director, Chief Policy Officer | HIMSHims & Hers Health, Inc. Grant or award | A | — 8,223 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Perez Garcia Andrea GDirector | HIMSHims & Hers Health, Inc. Grant or award | A | — 8,223 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Haas JasonDirector |  LGNDLIGAND PHARMACEUTICALS INCOption exercise | M | — 6,138 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Russell Alan JDirector, Chief Scientific Officer | EWTXEdgewise Therapeutics, Inc. Grant or award | A | — 32.5K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 5 | Akerib AvidanVP, Associative Computing |  GSITGSI TECHNOLOGY INCGrant or award | A | — 40.0K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 4 | Clark KyleDirector, SEE REMARKS |  BETABETA Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $763K 30.0K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 4 | Clark KyleDirector, SEE REMARKS | BETABETA Technologies, Inc. Open-market sale · 10b5-1 plan | SELL | $352K 15.0K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 2 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $410K 7,171 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 2 | Chuang Patrick T.Senior VP, Memory Design | GSITGSI TECHNOLOGY INC Grant or award | A | — 40.0K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 1 | McNamara PeterChief Scientific Officer |  TECXTectonic Therapeutic, Inc.Open-market sale · 10b5-1 plan | SELL | $1,505 43 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 1 | Hooker David StevensDirector |  NPBNORTHPOINTE BANCSHARES INCOpen-market sale · 10b5-1 plan | SELL | $421 24 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 1 | Hooker David StevensDirector | NPBNORTHPOINTE BANCSHARES INC Open-market sale · 10b5-1 plan | SELL | $5,943 339 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 1 | Shackley Brian CharlesSVP, Chief Accounting Officer |  AVAVAeroVironment IncOpen-market sale · 10b5-1 plan | SELL | $41K 205 sh | Aug 14, 2026 traded Aug 14, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 7,171 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 2,074 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO |  MAZEMaze Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $168K 16.1K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | McNamara PeterChief Scientific Officer | TECXTectonic Therapeutic, Inc. Option exercise · 10b5-1 plan | M | — 43 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 16.1K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 16.2K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary |  VGVenture Global, Inc.Option exercise · 10b5-1 plan | M | $439K 555.6K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $145K 2,074 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $230K 3,348 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Rezvan MitraChief Accounting Officer |  SAILSailPoint, Inc.Open-market sale · 10b5-1 plan | SELL | $24K 1,214 sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary | VGVenture Global, Inc. Option exercise · 10b5-1 plan | M | — 555.6K sh | Aug 14, 2026 traded Aug 13, 2026 |
| 0 | Dageville BenoitDirector |  SNOWSnowflake Inc.Gift · 10b5-1 plan | G | — 16.7K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $160K 2,869 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 2,869 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 3,348 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 0 | McNamara PeterChief Scientific Officer | TECXTectonic Therapeutic, Inc. Option exercise · 10b5-1 plan | M | $633 43 sh | Aug 14, 2026 traded Aug 12, 2026 |
| 60 | Walsh ColinDirector |  ATTOAttovia Therapeutics, Inc.Open-market purchase | BUY | $1.78M 85.0K sh | Aug 13, 2026 traded Aug 5, 2026 |
| 59 | Oran BarisChief Financial Officer |  AMRZAmrize LtdOpen-market purchase | BUY | $142K 3,000 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 59 | Clark Stephen SChief People Officer | AMRZAmrize Ltd Open-market purchase | BUY | $249K 5,260 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 58 | RENAISSANCE TECHNOLOGIES LLC13F filer |  AMZNAMAZON COM INCNEW | BUY | $545.97M 2.29M sh | Aug 13, 2026 |
| 55 | Oran BarisChief Financial Officer | AMRZAmrize Ltd Open-market purchase | BUY | $141K 3,000 sh | Aug 13, 2026 traded Aug 12, 2026 |
| 55 |  Shri ThanedarDSelf |  AAPLApple Inc.Partial sale | SELL | $100K – $250K | Aug 13, 2026 traded Jan 9, 2026 |
| 55 |  Rick ScottRSpouse | Charlotte NC Water & Sewer Sys Revenue Bond Rate/Coupon: 5.0% Matures: 07/01/2054 Purchase | BUY | $250K – $500K | Aug 13, 2026 traded Feb 7, 2025 |